Showing 1 - 7 results of 7 for search 'Enzhuo Yang', query time: 0.03s Refine Results
  1. 1
    Adjunctive Zoledronate + IL-2 administrations enhance anti-tuberculosis Vγ2Vδ2 T-effector populations, and improve treatment outcome of multidrug-resistant tuberculosis1

    Adjunctive Zoledronate + IL-2 administrations enhance anti-tuberculosis Vγ2Vδ2 T-effector populations, and improve treatment outcome of multidrug-resistant tuberculosis1 by Hongbo Shen, Enzhuo Yang, Ming Guo, Rui Yang, Guixian Huang, Ying Peng, Wei Sha, Feifei Wang, Ling Shen

    Published 2022-12-01
    Get full text
    Article
  2. 2
    Multidrug-resistant tuberculosis (MDR-TB) strain infection in macaques results in high bacilli burdens in airways, driving broad innate/adaptive immune responses

    Multidrug-resistant tuberculosis (MDR-TB) strain infection in macaques results in high bacilli burdens in airways, driving broad innate/adaptive immune responses by Enzhuo Yang, Rui Yang, Ming Guo, Dan Huang, Wandang Wang, Zhuoran Zhang, Crystal Chen, Feifei Wang, Wenzhe Ho, Ling Shen, Heping Xiao, Zheng W. Chen, Hongbo Shen

    Published 2018-12-01
    Get full text
    Article
  3. 3
    A CD4+CD161+ T-Cell Subset Present in Unexposed Humans, Not Tb Patients, Are Fast Acting Cells That Inhibit the Growth of Intracellular Mycobacteria Involving CD161 Pathway, Perforin, and IFN-γ/Autophagy

    A CD4+CD161+ T-Cell Subset Present in Unexposed Humans, Not Tb Patients, Are Fast Acting Cells That Inhibit the Growth of Intracellular Mycobacteria Involving CD161 Pathway, Perfor... by Rui Yang, Rui Yang, Ying Peng, Jiang Pi, Yidian Liu, Enzhuo Yang, Xiaona Shen, Lan Yao, Ling Shen, Robert L. Modlin, Hongbo Shen, Wei Sha, Zheng W. Chen

    Published 2021-02-01
    Get full text
    Article
  4. 4
    Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection

    Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection by Jiang Pi, Zhiyi Zhang, Enzhuo Yang, Lingming Chen, Lingchan Zeng, Yiwei Chen, Richard Wang, Dan Huang, Shuhao Fan, Wensen Lin, Hongbo Shen, Jun-Fa Xu, Gucheng Zeng, Ling Shen

    Published 2022-01-01
    Get full text
    Article
  5. 5
    Macrophage targeted graphene oxide nanosystem synergize antibiotic killing and host immune defense for Tuberculosis Therapy

    Macrophage targeted graphene oxide nanosystem synergize antibiotic killing and host immune defense for Tuberculosis Therapy by Jiang Pi, Dongsheng Chen, Jiajun Wang, Enzhuo Yang, Jiayi Yang, Yilin Liu, Jiaqi Yu, Jiaojiao Xia, Xueqin Huang, Lingming Chen, Yongdui Ruan, Jun-Fa Xu, Fen Yang, Ling Shen

    Published 2024-10-01
    Get full text
    Article
  6. 6
    LncRNA SNHG16 Inhibits Intracellular M. tuberculosis Growth Involving Cathelicidin Pathway, Autophagy, and Effector Cytokines Production

    LncRNA SNHG16 Inhibits Intracellular M. tuberculosis Growth Involving Cathelicidin Pathway, Autophagy, and Effector Cytokines Production by Guixian Huang, Xiaocui Wu, Xuejiao Ji, Ying Peng, Juechu Wang, Xia Cai, Yihui Wang, Enzhuo Yang, Liying Zhu, Yuan Wu, Qin Sun, Ling Shen, Wei Sha, Hongbo Shen, Feifei Wang

    Published 2024-10-01
    Get full text
    Article
  7. 7
    Macrophage targeted iron oxide nanodecoys augment innate immunological and drug killings for more effective Mycobacterium Tuberculosis clearance

    Macrophage targeted iron oxide nanodecoys augment innate immunological and drug killings for more effective Mycobacterium Tuberculosis clearance by Ling Shen, Kangsheng Liao, Enzhuo Yang, Fen Yang, Wensen Lin, Jiajun Wang, Shuhao Fan, Xueqin Huang, Lingming Chen, Hongbo Shen, Hua Jin, Yongdui Ruan, Xing Liu, Gucheng Zeng, Jun-Fa Xu, Jiang Pi

    Published 2023-10-01
    Get full text
    Article

Search Tools: